Evidence-based medicine: the value of vision screening.

Area of Science:

• Ophthalmology
• Public Health
• Health Economics

Background:

• Evidence-based medicine (EBM) is the current standard for evaluating medical interventions.
• Vision screening aims to detect conditions like amblyopia early.

Purpose of the Study:

• To review EBM literature on vision screening effectiveness.
• To assess the value of vision screening using a value-based medicine (VBM) framework.
• To inform comparative effectiveness research.

Main Methods:

• Literature review applying EBM principles.
• Analysis of five core questions regarding vision screening: value, effectiveness, cost, treatment efficacy, and benefit.
• Consideration of clinical, human, and economic outcomes.

Main Results:

• Vision is inherently valuable.
• Evidence for screening effectiveness in detecting amblyopia is not definitive.
• Screening is relatively inexpensive, though some advocate for costlier mandatory exams.
• Treatment is effective with compliance, but can have negative social aspects.
• Economic returns on amblyopia detection are high (approx. 10:1 ROI); human value returns require further study.

Conclusions:

• More research is needed to confirm vision screening effectiveness.
• Vision screening processes are complex and require patient compliance for optimal outcomes.
• The value of vision screening should be assessed comprehensively, including clinical, human, and economic factors.